Insight Session

Testing Stabilization – How the Industry is Progressing Towards DSCSA Interoperability

Monday, August 19, 2024 8:00 AM – 9:00 AM

Boston Convention & Exhibition Center, Room 151

Last August, the FDA announced it was granting the pharmaceutical supply chain an additional 12 months of stabilization before the law would become effective. This time would allow for more companies to serialize product and have enough serialized product in the supply chain to be able to test how well the interoperable tracing system works. During this session we will hear how the testing is proceeding and what the findings are and learn about unexpected findings.

Kara Birk Director, Rx Inventory and Supply Chain H-E-B

Kara Birk has dedicated 28 years to H-E-B, where she has spent the last 11 years managing Pharmacy Supply Chain. Leading a team responsible for Rx Inventory, Reverse Logistics, CSOS, and Suspicious Order Monitoring, Kara thrives on collaborating with her team and industry suppliers to deliver top-notch pharmacy care to Texans.

Chris Hewell Director of Managed Care Publix Super Markets, Inc.

Chris currently serves as the Director of Managed Care with Publix Super Markets. In this role, he develops and directs the strategy for payer contracts, claim analytics, auditing, and retail pharmacy support teams.